Atlas Arteria Limited

Atlas Arteria Limited

MAQAF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.87B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Atlas Arteria LimitedAtlas Arteria Limited20.210.42%11%-0.3
$5.31

Target Price by Analysts

104.2% upsideAtlas Arteria Limited Target Price DetailsTarget Price
$0.59

Current Fair Value

77.3% downside

Overvalued by 77.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.87 Billion
Enterprise Value$5.26 Billion
Annual dividend$0.28
Dividend yield10.42%
Earnings per Share$0.18
Beta0.57
Outstanding Shares1,450,833,707

Return

Return on Equity11.45%ROE
Return on Assets8.39%
Return on Invested Capital4.76%

Valuation & Multiples

P/E Ratio20.19P/E Ratio
PEG239.49PEG
Price to Sales-Price to Sales
Price to Book Ratio0.87Price to Book Ratio
Enterprise Value to Revenue16.99
Enterprise Value to EBIT16.21
Enterprise Value to Net Income8
Total Debt to Enterprise0.31
Debt to Equity0.31Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 26, 2026
EPS
-$0.04
Est. $0.03
Revenue
$51.40 M
Est. $118.16 M

Next Earnings Call

Expected Date
February 24, 2027
EPS Estimate
$0.10
Consensus analyst estimate
Revenue Estimate
$52.59 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Atlas Arteria Limited

50 employees
CEO: Hugh Wehby DipInvRel

Atlas Arteria Limited specializes in the acquisition, development, and management of toll road assets. Among its key holdings is a 13.4% equity stake in Toll Road Investors Partnership II (TRIP II), the concessionaire responsible for the...

Questions & Answers